ClinicalTrials.Veeva

Menu

Comparison Between Oral Gabapentin Versus Diclofenac Sodium in Post-operative Analgesia Laparoscopic Cholecystectomy

S

Sohag University

Status

Enrolling

Conditions

Cholecystitis, Chronic

Treatments

Drug: Gabapentin
Drug: Diclofenac Sodium

Study type

Interventional

Funder types

Other

Identifiers

NCT07131527
Soh-Med--25-7-5MS

Details and patient eligibility

About

this study amis to compare between perioperative oral Gabapentin versus Diclofenac sodium on postoperative analgesia patients undergoing laparoscopic cholecystectomy

Enrollment

60 estimated patients

Sex

All

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age from 20 to 60 years old. Both sexes. American Society of Anesthesiologists (ASA) physical status I- II. Patients undergoing laparoscopic cholecystectomy.

Exclusion criteria

Patients with hypertension. Pregnant women. Obese patients with BMI >35 kg/m2. Alcoholics. Patients With DM Patient refusal

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

group A will receive oral Gabapentin
Active Comparator group
Description:
Patients included in this group will receive 600 mg of gabapentin 2 h before surgery.
Treatment:
Drug: Gabapentin
group B will receive diclofenac sodium
Active Comparator group
Description:
Patients included in this group will receive 100 mg diclofenac sodium 2 h before surgery.
Treatment:
Drug: Diclofenac Sodium

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed E Abdel Rahman, Professor; Manar Z Ismaiel, Resident

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems